Calendar Allogene Therapeutics, Inc.

Equities

ALLO

US0197701065

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
2.77 USD -7.82% Intraday chart for Allogene Therapeutics, Inc. +0.36% -13.71%

Chart calendar Allogene Therapeutics, Inc.

39d3ecbd57c89a94ebadfdf5.10F28r6otzw0CV1-uBg8WiCBCu8ZmU6IDuX0Mo4Gs3g.mxkkqOf-4VsFZTJN3kB2CRPqMt9W_XvNXtKVfLtx1DzuLACTzMrRSAFDPg~81ab12490d22a4f3298af0a3d8f3081d

Upcoming events on Allogene Therapeutics, Inc.

2024-06-05 11:00 am Annual General Meeting
2024-06-11 08:40 am Goldman Sachs Global Healthcare Conference
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-25 Q4 2024 Earnings Release (Projected)
2025-04-29 Q1 2025 Earnings Release (Projected)

Past events on Allogene Therapeutics, Inc.

2024-05-15 11:00 am RBC Capital Markets Global Healthcare Conference
2024-05-14 09:00 am Citizens JMP Life Sciences Conference
2024-05-13 05:00 pm Q1 2024 Earnings Call
2024-05-13 04:01 pm Q1 2024 Earnings Release
2024-04-15 03:00 pm CG Horizons in Oncology Virtual Conference
2024-03-14 05:00 pm Q4 2023 Earnings Call
2024-03-14 04:05 pm Q4 2023 Earnings Release
2024-03-06 09:10 am TD Cowen Health Care Conference
2024-02-14 12:00 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-07 11:30 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-18 03:30 pm B. Riley Securities Oncology Conference
2024-01-10 11:15 am JPMorgan Healthcare Conference
2024-01-04 05:00 pm Business Update Call
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4832
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 2095
2023-12-06 11:30 am JMP Securities Hematology and Oncology Summit
2023-11-15 08:30 am Jefferies London Healthcare Conference
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 302
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 283
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 279

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
38,5
38,4
0.31%
0,24
0,19
25.77%
0,10
0,13
-28.76%

0,95

EBITDA
Million USD
Released
Forecast
Spread
-198
-204
3.02%
-251
-250
-0.51%
-245
-258
4.75%
-321
-325
1.17%
-314
-294
-6.61%

-259

EBIT
Million USD
Released
Forecast
Spread
-202
-210
3.93%
-258
-263
1.77%
-256
-266
3.99%
-335
-341
1.68%
-328
-321
-2.09%

-289

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-185
-195
5.37%
-250
-257
2.69%
-257
-265
3%
-333
-340
2.12%
-327
-313
-4.44%

-278

Net income
Million USD
Released
Forecast
Spread
-185
-195
5.47%
-250
-257
2.62%
-257
-265
3.01%
-333
-339
1.97%
-327
-312
-4.73%

-279

EPS
USD
Released
Forecast
Spread
-1,83
-1,94
5.84%
-2,08
-2,14
2.71%
-1,89
-1,97
3.82%
-2,32
-2,37
2.18%
-2,09
-2,01
-3.96%

-1,61

Announcement Date27/02/2025/02/2123/02/2228/02/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,06
0,01
754.34%
0,09
0,02
444.65%
0,05
0,01
289.82%
0,05
0,06
-26.8%
0,05
0,01
677.28%
0,04
0,02
141.1%
0,04
0,01
347.92%
0,02
0,02
-6.25%
0,02
0,01
110.93%

1,01


0,01


0,01


0,02


0,02

EBITDA
Million USD
Released
Forecast
Spread
-76,3
-82,0
6.95%
-72,9
-84,0
13.19%
-78,6
-86,0
8.57%
-93,3
-94,6
1.41%
-95,6
-90,0
-6.18%
-76,9
-80,9
4.97%
-59,4
-76,1
21.95%
-81,6
-58,2
-40.23%

-68,4


-64,9


-64,5


-64,1


-69,1


-69,1

EBIT
Million USD
Released
Forecast
Spread
-80,0
-83,2
3.82%
-76,6
-87,4
12.32%
-82,5
-95,1
13.26%
-96,4
-102
5.59%
-99,1
-88,8
-11.51%
-80,5
-86,5
6.91%
-63,0
-81,1
22.3%
-85,1
-78,4
-8.58%
-69,5
-69,6
0.12%

-67,4


-70,1


-73,9


-77,6


-79,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-79,9
-82,5
3.25%
-74,8
-85,9
12.92%
-83,1
-93,0
10.61%
-94,8
-102
7.04%
-98,7
-88,0
-12.12%
-78,0
-86,2
9.55%
-61,3
-79,1
22.47%
-85,8
-75,2
-14.02%
-65,0
-68,1
4.5%

-64,7


-67,6


-69,9


-74,9


-76,8

Net income
Million USD
Released
Forecast
Spread
-79,9
-82,4
3.15%
-74,8
-86,0
13.09%
-83,1
-92,5
10.15%
-94,8
-101
5.9%
-98,7
-88,9
-10.99%
-78,0
-86,3
9.6%
-61,3
-78,9
22.29%
-85,8
-74,4
-15.33%
-65,0
-68,0
4.42%

-65,3


-68,1


-70,6


-74,9


-76,8

EPS
USD
Released
Forecast
Spread
-0,56
-0,58
3.19%
-0,52
-0,60
13.99%
-0,58
-0,64
9.38%
-0,66
-0,70
5.65%
-0,68
-0,62
-9.47%
-0,53
-0,59
10.58%
-0,37
-0,52
28.86%
-0,51
-0,45
-12.39%
-0,38
-0,41
6.93%

-0,36


-0,36


-0,37


-0,38


-0,38

Announcement Date04/05/2209/08/2202/11/2228/02/2303/05/2302/08/2302/11/2314/03/2413/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALLO Stock
  4. Calendar Allogene Therapeutics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW